Lipocine (LPCN) 10-Q2020 Q1 Quarterly report

Filed: 7 May 20, 8:01am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: Abady, accomplishment, adhere, alternative, animal, art, ballooning, biomarker, breadth, bulk, capacity, Capsugel, cGMP, challenge, challenged, challenging, China, circulating, Citizen, clock, complexity, constrain, cooperate, cooperation, countersue, coverage, decide, deferral, deliver, diet, difficult, disaster, dispute, disrupt, disrupted, disruption, dissuade, Distinguishing, division, dramatically, economy, efficiency, effort, emergency, enacted, Encap, encephalopathy, essential, evolve, exceed, forecast, foreign, forgiven, frail, fundamental, GAAP, gain, global, ground, half, healthcare, HFD, highlighted, hospital, impede, imposed, inability, increasingly, induced, infrastructure, input, instrument, insufficient, inter, interrupt, invoking, issuedAccounting, Kingdom, leave, lent, licensor, list, local, logistical, Lonza, methodology, month, mortgage, movement, narrower, narrowing, novelty, ongoingLiFT, outbreak, pandemic, Paycheck, payroll, perception, pharmacological, PPP, President, prioritized, proceeding, prostate, quarantine, rabbit, reaction, reclassified, reexamination, refuse, reliance, repurchase, retained, retention, scientific, seminal, sensitivity, smaller, spread, Stafford, strain, streamline, strength, strike, supplier, Supreme, surfaced, text, threatened, unenforceability, unenforceable, upheld, vesicle, voluntarily, waitlisted, warrant, warranty, withdraw, workforce, world, worldwide, Wuhan

Removed: acknowledged, agree, alteration, anemia, appeal, atrophy, BRUDAC, call, Child, Circuit, combined, commercialized, country, decision, decompensation, decreased, deny, disposition, dysfunction, extensive, fall, fatigue, gynecomastia, hair, impaired, invent, invention, Jantenzo, judgement, judgment, line, marketed, marketplace, muscle, Physiciansroutinely, position, priority, proceed, profitable, progressively, provisional, PTAB, Pugh, put, redeclared, reportable, request, resubmit, ruling, sarcopenia, secure, senior, September, sexual, statistically, substantive, Subtopic, surveillance, team, testicular, transplantation, wasting, withdrawn, working, worsening

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

LPCN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION

In connection with the Quarterly Report on Form 10-Q of Lipocine Inc. (the “Corporation”) for the quarter ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Morgan R. Brown, Executive Vice President and Chief Financial Officer of the Corporation, hereby certifies, pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

Dated: May 7, 2020

/s/ Morgan R. Brown

Morgan R. Brown, Executive Vice President and

Chief Financial Officer

(Principal Financial and Accounting Officer)